<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.dottnet.it/articolo/32543935/farmaci-glp-1-le-donne-restano-le-principali-utilizzatrici</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmaci GLP-1, le donne restano le principali utilizzatrici</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543935-anteprimearticolidottnet-2026-10-05t100235582.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543934/salute-respiratoria-al-congresso-sip-ambiente-prevenzione-e-nuove-frontiere-della-pneumologia</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Salute respiratoria, al congresso SIP ambiente, prevenzione e nuove frontiere della pneumologia</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543934-anteprimearticolidottnet-2026-10-05t094909749.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543936/tumori-urologici-migliaia-nuove-diagnosi-ogni-anno-la-medicina-punta-sempre-piu-su-cure-su-misura</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumori urologici, migliaia nuove diagnosi ogni anno: la medicina punta sempre più su cure su misura</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543936-anteprimearticolidottnet-2026-10-05t101252051.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543938/tubercolosi-nei-bambini-al-meyer-arriva-la-terapia-che-si-scioglie-in-acqua</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tubercolosi nei bambini, al Meyer arriva la terapia che si scioglie in acqua</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543938-anteprimearticolidottnet-2026-10-05t104234373.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543937/cardiomiopatia-ipertrofica-ostruttiva-diagnosi-ancora-tardive-al-congresso-esc-i-dati-a-cinque-anni-di-mavacamten</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Cardiomiopatia ipertrofica ostruttiva, diagnosi ancora tardive: al congresso ESC i dati a cinque anni di mavacamten</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543937-anteprimearticolidottnet-2026-10-05t101925675.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543939/schillaci-piu-risorse-alla-sanita-al-mef-un-nuovo-piano-di-spesa</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Schillaci: &#34;Più risorse alla sanità&#34;. Al Mef un nuovo piano di spesa</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543939-schillaci.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543940/sanita-piu-miliardi-ma-la-spesa-resta-ferma-al-6-3-del-pil</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sanità, più miliardi ma la spesa resta ferma al 6,3% del Pil</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543940-spesasanitaria5.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543941/vaccini-bassetti-denuncia-lo-scontro-politico-ma-a-milano-crescono-le-adesioni</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Vaccini, Bassetti denuncia lo scontro politico. Ma a Milano crescono le adesioni</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543941-vaccinoantinfluenzale2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543942/nobel-per-la-medicina-a-deisseroth-hegemann-e-nagel-cos-e-l-optogenetica</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Nobel per la Medicina a Deisseroth, Hegemann e Nagel: cos&#39;è l&#39;optogenetica</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543942-nobelmedicina.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543943/siti-piu-donne-tra-gli-iscritti-ma-meno-ai-vertici-parte-il-piano-per-l-equita</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>SItI, più donne tra gli iscritti ma meno ai vertici: parte il piano per l&#39;equità</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543943-genderequality.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543944/salute-globale-cambia-la-mappa-delle-malattie-il-74-dei-decessi-e-per-patologie-croniche</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Salute globale, cambia la mappa delle malattie: il 74% dei decessi è per patologie croniche</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543944-aspettativadivita.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543945/retatrutide-nel-diabete-tipo-2-perdita-di-peso-oltre-il-20-nello-studio-triumph-2</loc>
  <lastmod>2026-10-05T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Retatrutide, nel diabete tipo 2 perdita di peso oltre il 20% nello studio TRIUMPH-2</news:title>
   <news:publication_date>2026-10-05</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543945-obesitywomanweighingonscaleathospital.jpg</image:loc>
  </image:image>
 </url>
</urlset>